1.67% -0.4299

Catalyst Pharmaceuticals Inc (CPRX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt CPRX? Forum Prognose

Finanzdaten der Catalyst Pharmaceuticals Inc-Aktie (CPRX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	2.84% 152.61	148.39	146.56	141.42	141.82
Cost Of Revenue	15.10% 26.07	22.65	20.61	17.91	21.64
Gross Profit	0.64% 126.54	125.74	125.95	123.51	120.18
Operating Expenses	10.18% 55.23	50.13	50.31	50.80	19.96
Benefits Costs and Expenses	4.34% 80.71	77.36	77.27	70.14	67.64
Costs And Expenses	4.34% 80.71	77.36	77.27	70.14	67.64
Operating Income/Loss	6.67% 61.85	66.27	66.30	63.37	62.84
Income/Loss From Continuing Operations Before Tax	1.22% 71.90	71.03	69.29	71.29	74.18
Income Tax Expense/Benefit	5.21% 19.20	18.25	17.18	14.55	18.25
Income/Loss From Continuing Operations After Tax	0.16% 52.70	52.78	52.11	56.74	55.94
Net Income/Loss	0.16% 52.70	52.78	52.11	56.74	55.94
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.83% 0.208	122.60	122.16	121.47	0.4816
Diluted Average Shares	99.96% 0.056	127.09	127.54	126.96	0.4238
Basic Earnings Per Share	0.00% 0.43	0.43	0.43	0.47	0.46
Diluted Earnings Per Share	2.38% 0.41	0.42	0.41	0.45	0.44
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$46.06

0.41%

ROIV

$28.99

1.33%

MRNA

$54.07

1.61%

BNTX

$90.20

0.16%

INSM

$141.15

1.23%

ONC

$288.30

0.99%